# Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

Study · id `cardio:ct-nct03520972` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03520972](<https://clinicaltrials.gov/study/NCT03520972>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03520972

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 251 participants.

## Technical summary

Registry record NCT03520972. Randomized; triple masking; primary purpose treatment. Start 2018-06-05 (actual); primary completion 2019-07-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 251 participants (enrolled count; ClinicalTrials.gov record NCT03520972, source copy `cardio:ctgov-nct03520972-2020-01-22`, retrieved 2026-10-26)
- Started: 2018-06-05 (actual) (ClinicalTrials.gov record NCT03520972, source copy `cardio:ctgov-nct03520972-2020-01-22`, retrieved 2026-10-26)
- Primary completion: 2019-07-29 (actual) (ClinicalTrials.gov record NCT03520972, source copy `cardio:ctgov-nct03520972-2020-01-22`, retrieved 2026-10-26)
- Completion: 2019-07-29 (actual) (ClinicalTrials.gov record NCT03520972, source copy `cardio:ctgov-nct03520972-2020-01-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03520972, source copy `cardio:ctgov-nct03520972-2020-01-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03520972-2020-01-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): PB-119 75ug
- Intervention (Drug): PB-119 150ug
- Intervention (Drug): PB-119 200ug
- Intervention (Drug): placebo
- Lead sponsor: PegBio Co., Ltd.
- Lead sponsor class: OTHER
- Collaborator: Tigermed Consulting Co., Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: PegBio Co., Ltd. (`cardio:org-pegbio-co-ltd`)
- Registry lists this organization as a collaborator: Tigermed Consulting Co., Ltd (`cardio:org-tigermed-consulting-co-ltd`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study (`cardio:pubmed-33687487`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0ee254fdab47912f384e7b0f017ca10506b0a979f898d64f71fcd5b0a3589795
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
